Stryker Corp (SYK.BE)
| Previous close | 314.10 |
| Open | 315.90 |
| Bid | 315.30 x 0 |
| Ask | 315.80 x 0 |
| Day's range | 315.90 - 315.90 |
| 52-week range | 240.10 - 330.30 |
| Volume | |
| Avg. volume | 3 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 30 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Stryker Corp (SYK) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Optimistic ...
Discover how Stryker Corp achieved significant sales growth and raised its full-year forecasts amidst dynamic market conditions.
- Reuters
REFILE-Stryker lifts 2024 profit forecast on strong demand for medical devices, implants
Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants. The joint-implant maker now sees its annual profit per share to be between $11.85 and $12.05, raised from the previous range of between $11.70 and $12. Stryker now expects organic net sales growth for 2024 to be in the range of 8.5% to 9.5%, compared with its earlier projected range of 7.5% to 9%.
ZacksHere's What Key Metrics Tell Us About Stryker (SYK) Q1 Earnings
The headline numbers for Stryker (SYK) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
